However, scRNA+TCRαβ-seq data from HLA-A*02:01 + CML patients showed how the anti-PR1 T cell profile is highly cytotoxic in a patient who maintained the TFR, but larger study cohorts are needed to confirm these results. This evidence concerns the gene TMEM37 and chronic myelogenous leukemia, BCR-ABL1 positive.